HEADER TRANSCRIPTION/AGONIST 29-NOV-17 6BR2
TITLE STRUCTURE OF RORGT IN COMPLEX WITH A NOVEL ISOQUINOLINE INVERSE
TITLE 2 AGONIST.
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1
COMPND 5 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED
COMPND 6 ORPHAN RECEPTOR-GAMMA;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS NUCLEAR HORMONE RECEPTOR, INVERSE AGONIST, COMPLEX, TRANSCRIPTION-
KEYWDS 2 AGONIST COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR R.J.SKENE,I.HOFFMAN
REVDAT 3 13-MAR-24 6BR2 1 REMARK
REVDAT 2 25-APR-18 6BR2 1 JRNL
REVDAT 1 21-MAR-18 6BR2 0
JRNL AUTH M.KONO,A.OCHIDA,T.ODA,T.IMADA,Y.BANNO,N.TAYA,S.MASADA,
JRNL AUTH 2 T.KAWAMOTO,K.YONEMORI,Y.NARA,Y.FUKASE,T.YUKAWA,H.TOKUHARA,
JRNL AUTH 3 R.SKENE,B.C.SANG,I.D.HOFFMAN,G.P.SNELL,K.UGA,A.SHIBATA,
JRNL AUTH 4 K.IGAKI,Y.NAKAMURA,H.NAKAGAWA,N.TSUCHIMORI,M.YAMASAKI,
JRNL AUTH 5 J.SHIRAI,S.YAMAMOTO
JRNL TITL DISCOVERY OF [ CIS-3-({(5
JRNL TITL 2 R)-5-[(7-FLUORO-1,1-DIMETHYL-2,3-DIHYDRO-1
JRNL TITL 3 H-INDEN-5-YL)CARBAMOYL]-2-METHOXY-7,8-DIHYDRO-1,
JRNL TITL 4 6-NAPHTHYRIDIN-6(5 H)-YL}CARBONYL)CYCLOBUTYL]ACETIC ACID
JRNL TITL 5 (TAK-828F) AS A POTENT, SELECTIVE, AND ORALLY AVAILABLE
JRNL TITL 6 NOVEL RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR GAMMA T
JRNL TITL 7 INVERSE AGONIST.
JRNL REF J. MED. CHEM. V. 61 2973 2018
JRNL REFN ISSN 1520-4804
JRNL PMID 29510038
JRNL DOI 10.1021/ACS.JMEDCHEM.8B00061
REMARK 2
REMARK 2 RESOLUTION. 3.18 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.18
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.23
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 3 NUMBER OF REFLECTIONS : 11396
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.178
REMARK 3 R VALUE (WORKING SET) : 0.175
REMARK 3 FREE R VALUE : 0.227
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900
REMARK 3 FREE R VALUE TEST SET COUNT : 589
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3475
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 86
REMARK 3 SOLVENT ATOMS : 18
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 107.6
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.60000
REMARK 3 B22 (A**2) : 0.60000
REMARK 3 B33 (A**2) : -1.96000
REMARK 3 B12 (A**2) : 0.30000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): NULL
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.411
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.323
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 43.838
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : NULL ; NULL
REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : NULL ; NULL
REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : NULL ; NULL
REMARK 3 STAGGERED (DEGREES) : NULL ; NULL
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED
REMARK 4
REMARK 4 6BR2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-NOV-17.
REMARK 100 THE DEPOSITION ID IS D_1000231307.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 29-JUN-13
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ALS
REMARK 200 BEAMLINE : 5.0.3
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12017
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.180
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : 4.700
REMARK 200 R MERGE (I) : 0.06100
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.18
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.23
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 4.80
REMARK 200 R MERGE FOR SHELL (I) : 0.94000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 65.94
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.61
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 2%MPD, 1.2M NAFORMATE, 0.1M HEPES 7.5,
REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+1/3
REMARK 290 3555 -X+Y,-X,Z+2/3
REMARK 290 4555 -X,-Y,Z+1/2
REMARK 290 5555 Y,-X+Y,Z+5/6
REMARK 290 6555 X-Y,X,Z+1/6
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.82800
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 83.65600
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 62.74200
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 104.57000
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 20.91400
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 SER B 477
REMARK 465 GLN B 478
REMARK 465 HIS B 479
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 266 -153.03 -108.28
REMARK 500 GLN A 286 -54.99 63.95
REMARK 500 GLU A 435 75.34 -101.53
REMARK 500 SER A 477 -73.77 -97.92
REMARK 500 GLN B 286 -56.82 67.13
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue E3S A 502
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue MPD B 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue E3S B 502
DBREF 6BR2 A 265 479 UNP P51449 RORG_HUMAN 265 479
DBREF 6BR2 B 265 479 UNP P51449 RORG_HUMAN 265 479
SEQRES 1 A 215 ALA SER LEU THR GLU ILE GLU HIS LEU VAL GLN SER VAL
SEQRES 2 A 215 CYS LYS SER TYR ARG GLU THR CYS GLN LEU ARG LEU GLU
SEQRES 3 A 215 ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SER ARG GLU
SEQRES 4 A 215 GLU VAL THR GLY TYR GLN ARG LYS SER MET TRP GLU MET
SEQRES 5 A 215 TRP GLU ARG CYS ALA HIS HIS LEU THR GLU ALA ILE GLN
SEQRES 6 A 215 TYR VAL VAL GLU PHE ALA LYS ARG LEU SER GLY PHE MET
SEQRES 7 A 215 GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU LEU LYS ALA
SEQRES 8 A 215 GLY ALA MET GLU VAL VAL LEU VAL ARG MET CYS ARG ALA
SEQRES 9 A 215 TYR ASN ALA ASP ASN ARG THR VAL PHE PHE GLU GLY LYS
SEQRES 10 A 215 TYR GLY GLY MET GLU LEU PHE ARG ALA LEU GLY CYS SER
SEQRES 11 A 215 GLU LEU ILE SER SER ILE PHE ASP PHE SER HIS SER LEU
SEQRES 12 A 215 SER ALA LEU HIS PHE SER GLU ASP GLU ILE ALA LEU TYR
SEQRES 13 A 215 THR ALA LEU VAL LEU ILE ASN ALA HIS ARG PRO GLY LEU
SEQRES 14 A 215 GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN TYR ASN LEU
SEQRES 15 A 215 GLU LEU ALA PHE HIS HIS HIS LEU CYS LYS THR HIS ARG
SEQRES 16 A 215 GLN SER ILE LEU ALA LYS LEU PRO PRO LYS GLY LYS LEU
SEQRES 17 A 215 ARG SER LEU CYS SER GLN HIS
SEQRES 1 B 215 ALA SER LEU THR GLU ILE GLU HIS LEU VAL GLN SER VAL
SEQRES 2 B 215 CYS LYS SER TYR ARG GLU THR CYS GLN LEU ARG LEU GLU
SEQRES 3 B 215 ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SER ARG GLU
SEQRES 4 B 215 GLU VAL THR GLY TYR GLN ARG LYS SER MET TRP GLU MET
SEQRES 5 B 215 TRP GLU ARG CYS ALA HIS HIS LEU THR GLU ALA ILE GLN
SEQRES 6 B 215 TYR VAL VAL GLU PHE ALA LYS ARG LEU SER GLY PHE MET
SEQRES 7 B 215 GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU LEU LYS ALA
SEQRES 8 B 215 GLY ALA MET GLU VAL VAL LEU VAL ARG MET CYS ARG ALA
SEQRES 9 B 215 TYR ASN ALA ASP ASN ARG THR VAL PHE PHE GLU GLY LYS
SEQRES 10 B 215 TYR GLY GLY MET GLU LEU PHE ARG ALA LEU GLY CYS SER
SEQRES 11 B 215 GLU LEU ILE SER SER ILE PHE ASP PHE SER HIS SER LEU
SEQRES 12 B 215 SER ALA LEU HIS PHE SER GLU ASP GLU ILE ALA LEU TYR
SEQRES 13 B 215 THR ALA LEU VAL LEU ILE ASN ALA HIS ARG PRO GLY LEU
SEQRES 14 B 215 GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN TYR ASN LEU
SEQRES 15 B 215 GLU LEU ALA PHE HIS HIS HIS LEU CYS LYS THR HIS ARG
SEQRES 16 B 215 GLN SER ILE LEU ALA LYS LEU PRO PRO LYS GLY LYS LEU
SEQRES 17 B 215 ARG SER LEU CYS SER GLN HIS
HET MPD A 501 8
HET E3S A 502 35
HET MPD B 501 8
HET E3S B 502 35
HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL
HETNAM E3S (1R)-N-(4-TERT-BUTYL-3-FLUOROPHENYL)-6-METHOXY-2-[(3-
HETNAM 2 E3S OXO-2,3-DIHYDRO-1,2-OXAZOL-5-YL)ACETYL]-1,2,3,4-
HETNAM 3 E3S TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE
FORMUL 3 MPD 2(C6 H14 O2)
FORMUL 4 E3S 2(C26 H28 F N3 O5)
FORMUL 7 HOH *18(H2 O)
HELIX 1 AA1 SER A 266 GLU A 283 1 18
HELIX 2 AA2 ARG A 288 ARG A 296 1 9
HELIX 3 AA3 SER A 301 LYS A 311 1 11
HELIX 4 AA4 SER A 312 ARG A 337 1 26
HELIX 5 AA5 CYS A 345 MET A 365 1 21
HELIX 6 AA6 GLY A 384 GLY A 392 5 9
HELIX 7 AA7 CYS A 393 LEU A 410 1 18
HELIX 8 AA8 SER A 413 ILE A 426 1 14
HELIX 9 AA9 GLU A 435 THR A 457 1 23
HELIX 10 AB1 SER A 461 LEU A 466 1 6
HELIX 11 AB2 SER B 266 THR B 284 1 19
HELIX 12 AB3 ARG B 288 GLN B 295 1 8
HELIX 13 AB4 ARG B 296 ASN B 298 5 3
HELIX 14 AB5 SER B 301 LYS B 311 1 11
HELIX 15 AB6 SER B 312 ARG B 337 1 26
HELIX 16 AB7 CYS B 345 ALA B 355 1 11
HELIX 17 AB8 GLY B 356 MET B 365 1 10
HELIX 18 AB9 GLY B 384 GLY B 392 5 9
HELIX 19 AC1 CYS B 393 LEU B 410 1 18
HELIX 20 AC2 SER B 413 ILE B 426 1 14
HELIX 21 AC3 GLU B 435 THR B 457 1 23
HELIX 22 AC4 ARG B 459 LEU B 463 5 5
SHEET 1 AA1 3 TYR A 369 ASN A 370 0
SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370
SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O GLY A 383 N VAL A 376
SHEET 1 AA2 3 TYR B 369 ASN B 370 0
SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370
SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O GLY B 383 N VAL B 376
SITE 1 AC1 4 GLU A 304 TYR A 308 LYS A 311 ARG A 319
SITE 1 AC2 11 GLN A 286 CYS A 320 HIS A 323 LEU A 324
SITE 2 AC2 11 ARG A 364 MET A 365 PHE A 377 PHE A 378
SITE 3 AC2 11 GLU A 379 GLY A 380 PHE A 388
SITE 1 AC3 6 GLU B 290 GLU B 304 GLY B 307 TYR B 308
SITE 2 AC3 6 LYS B 311 ARG B 319
SITE 1 AC4 10 GLN B 286 CYS B 320 HIS B 323 LEU B 324
SITE 2 AC4 10 ARG B 364 PHE B 377 PHE B 378 GLU B 379
SITE 3 AC4 10 GLY B 380 PHE B 388
CRYST1 99.842 99.842 125.484 90.00 90.00 120.00 P 61 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010016 0.005783 0.000000 0.00000
SCALE2 0.000000 0.011565 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007969 0.00000